EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Clinical Efficacy of Probiotics for Relieving Cold Symptoms in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Lisa Lungaro iD, Patrizia Malfa iD, Francesca Manza iD, Matilde Negrelli iD, Anna Costanzini iD, Diletta Francesca Squarzanti iD, Marta Lo Re, Alessio Cariani, Sara Ghisellini iD, Fabio Caputo iD, Alfredo De Giorgi, Pasquale Mansueto iD und 3 weitere

Nutrients · 28.04.2025 · 17 (9) · 1490

DOI: 10.3390/nu17091490 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, online erschienen am 28.04.2025. Verfasst von Lisa Lungaro und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy. Hauptthemen laut MEDLINE: Probiotics, Common Cold. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Ferrara (FAR and FIRD 2024 funds), Synbalance srl.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colds are widespread infectious diseases that affect daily life, increasing healthcare costs and limiting productivity.

Objectives

The aim of this study was to investigate the effects of a dietary supplement containing specific probiotic strains (L. plantarum PBS067, L. acidophilus PBS066, B. lactis BL050) on cold symptom relief, immune response enhancement, and quality of life.

Methods

This randomized, double-blind, placebo-controlled trial included 65 healthy volunteers (age range: 18–44 years), divided into two groups: 40 received the probiotic treatment (with vitamins and bulking agents), and 25 received placebo (vitamins and bulking agents only) for 12 weeks. Cold symptoms and systemic inflammation were assessed at three time points (baseline T0, post-treatment T1, and 6 weeks after treatment T2).

Results

Probiotics were associated with a shorter average duration of cold symptoms (4.5 vs. 6.7% for Placebo, p < 0.05). At T1, fever and muscle pain occurred in 20% of participants in the Probiotic group vs. 28% and 44% in the Placebo group, respectively (p < 0.05 for muscle pain vs. Placebo). For muscle pain, a trend was maintained also at T2 (17.5% vs. 20%). The pro-inflammatory cytokine IFN-γ levels significantly decreased in the Probiotic group vs. T0 (p < 0.0001 at T1 and p < 0.01 at T2), while they increased in the Placebo group (22.279 ± 3.538 vs. 19.432 ± 3.143 pg/mL, p = NS). Although not statistically significant, at T1 the Probiotic group had higher levels of IL-10 vs. T0 (266.98 ± 78.432 vs. 240.967 ± 70.238, pg/mL p = NS).

Conclusions

The probiotic mix effectively alleviated cold symptoms and reduced pro-inflammatory cytokine levels, suggesting anti-inflammatory effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsCommon ColdHumansDouble-Blind MethodAdultMaleFemaleYoung AdultAdolescentHealthy VolunteersQuality of LifeTreatment OutcomeDietary SupplementsMyalgiaCytokines

Stichwörter der Autor:innen

URTIscold symptomsfood supplementsimmunityprobiotics

Substanzen

Cytokines

Autor:innen und Institutionen

  • Department of Translational Medicine, University of Ferrara, 44121 Ferrara, Italy.
  • Geriatric Unit, P. Giaccone University Hospital, 90127 Palermo, Italy.
  • SynBalance srl, 21040 Origgio, Italy.
  • Academic Unit of Gastroenterology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S5 7AT, UK.
  • Clinical Pathology Unit, S. Anna University Hospital, 44124 Ferrara, Italy.
  • Unit of Internal Medicine, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", 90146 Palermo, Italy.

ORCID-Profile: Lisa Lungaro, Patrizia Malfa, Francesca Manza, Matilde Negrelli, Anna Costanzini, Diletta Francesca Squarzanti, Sara Ghisellini, Fabio Caputo, Pasquale Mansueto, Antonio Carroccio, Roberto De Giorgio, Giacomo Caio

Förderung

  • University of Ferrara (FAR and FIRD 2024 funds)
  • Synbalance srl

Zitieren

APA

Lungaro, L., Malfa, P., Manza, F., Negrelli, M., Costanzini, A., Squarzanti, D. F., Lo Re, M., Cariani, A., Ghisellini, S., Caputo, F., De Giorgi, A., Mansueto, P., Carroccio, A., De Giorgio, R., & Caio, G. (2025). Clinical Efficacy of Probiotics for Relieving Cold Symptoms in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients, 17(9), 1490. https://doi.org/10.3390/nu17091490

Vancouver

Lungaro L, Malfa P, Manza F, Negrelli M, Costanzini A, Squarzanti DF, et al. Clinical Efficacy of Probiotics for Relieving Cold Symptoms in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. 2025;17(9):1490. doi:10.3390/nu17091490

BibTeX
@article{Lungaro2025,
  author = {Lungaro, Lisa and Malfa, Patrizia and Manza, Francesca and Negrelli, Matilde and Costanzini, Anna and Squarzanti, Diletta Francesca and Lo Re, Marta and Cariani, Alessio and Ghisellini, Sara and Caputo, Fabio and De Giorgi, Alfredo and Mansueto, Pasquale and Carroccio, Antonio and De Giorgio, Roberto and Caio, Giacomo},
  title = {Clinical Efficacy of Probiotics for Relieving Cold Symptoms in Healthy Individuals: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {9},
  pages = {1490},
  doi = {10.3390/nu17091490}
}
Kostenlos starten →